189 related articles for article (PubMed ID: 36735054)
1. Loss of lower extremity bone mineral density 1 year after denosumab is discontinued in persons with subacute spinal cord injury.
Cirnigliaro CM; La Fountaine MF; Parrott JS; Kirshblum SC; Sauer SJ; Shapses SA; McClure IA; Bauman WA
Osteoporos Int; 2023 Apr; 34(4):741-748. PubMed ID: 36735054
[TBL] [Abstract][Full Text] [Related]
2. Administration of Denosumab Preserves Bone Mineral Density at the Knee in Persons With Subacute Spinal Cord Injury: Findings From a Randomized Clinical Trial.
Cirnigliaro CM; La Fountaine MF; Parrott JS; Kirshblum SC; McKenna C; Sauer SJ; Shapses SA; Hao L; McClure IA; Hobson JC; Spungen AM; Bauman WA
JBMR Plus; 2020 Aug; 4(8):e10375. PubMed ID: 33134767
[TBL] [Abstract][Full Text] [Related]
3. Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.
Gifre L; Vidal J; Carrasco JL; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
Osteoporos Int; 2016 Jan; 27(1):405-10. PubMed ID: 26423406
[TBL] [Abstract][Full Text] [Related]
4. Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.
Gifre L; Ruiz-Gaspà S; Carrasco JL; Portell E; Vidal J; Muxi A; Monegal A; Guañabens N; Peris P
Osteoporos Int; 2017 Sep; 28(9):2707-2715. PubMed ID: 28580511
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study.
Bauman WA; Cirnigliaro CM; La Fountaine MF; Martinez L; Kirshblum SC; Spungen AM
J Bone Miner Metab; 2015 Jul; 33(4):410-21. PubMed ID: 25158630
[TBL] [Abstract][Full Text] [Related]
6. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial.
Miller PD; Bolognese MA; Lewiecki EM; McClung MR; Ding B; Austin M; Liu Y; San Martin J
Bone; 2008 Aug; 43(2):222-229. PubMed ID: 18539106
[TBL] [Abstract][Full Text] [Related]
7. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass.
Bone HG; Bolognese MA; Yuen CK; Kendler DL; Miller PD; Yang YC; Grazette L; San Martin J; Gallagher JC
J Clin Endocrinol Metab; 2011 Apr; 96(4):972-80. PubMed ID: 21289258
[TBL] [Abstract][Full Text] [Related]
8. Progressive Sublesional Bone Loss Extends into the Second Decade After Spinal Cord Injury.
Cirnigliaro CM; Myslinski MJ; Asselin P; Hobson JC; Specht A; La Fountaine MF; Kirshblum SC; Forrest GF; Dyson-Hudson T; Spungen AM; Bauman WA
J Clin Densitom; 2019; 22(2):185-194. PubMed ID: 30503961
[TBL] [Abstract][Full Text] [Related]
9. The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study.
Oleson CV; Marino RJ; Formal CS; Modlesky CM; Leiby BE
Spinal Cord; 2020 Aug; 58(8):921-929. PubMed ID: 32055041
[TBL] [Abstract][Full Text] [Related]
10. Open-label clinical trial of alendronate after teriparatide therapy in people with spinal cord injury and low bone mineral density.
Haider IT; Simonian N; Saini AS; Leung FM; Edwards WB; Schnitzer TJ
Spinal Cord; 2019 Oct; 57(10):832-842. PubMed ID: 31164732
[TBL] [Abstract][Full Text] [Related]
11. Follow-Up of Bone Mineral Density Changes in de novo Kidney Transplant Recipients Treated with Two Doses of the Receptor Activator of Nuclear Factor κB Ligand Inhibitor Denosumab.
Kobel C; Frey D; Graf N; Wüthrich RP; Bonani M
Kidney Blood Press Res; 2019; 44(5):1285-1293. PubMed ID: 31614356
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Distal Femur and Proximal Tibia Bone Mineral Density From Total Body Dual Energy X-Ray Absorptiometry Scans in Persons with Spinal Cord Injury.
Ghatas MP; Sutor TW; Gorgey AS
J Clin Densitom; 2022; 25(2):252-260. PubMed ID: 34920939
[TBL] [Abstract][Full Text] [Related]
13. Trabecular Bone Score at the Distal Femur and Proximal Tibia in Individuals With Spinal Cord Injury.
Lobos S; Cooke A; Simonett G; Ho C; Boyd SK; Edwards WB
J Clin Densitom; 2019; 22(2):249-256. PubMed ID: 29776736
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Bone Mineral Density at the Distal Femur and the Proximal Tibia by Dual-Energy X-ray Absorptiometry in Individuals With Spinal Cord Injury: Precision of Protocol and Relation to Injury Duration.
Lobos S; Cooke A; Simonett G; Ho C; Boyd SK; Edwards WB
J Clin Densitom; 2018; 21(3):338-346. PubMed ID: 28662973
[TBL] [Abstract][Full Text] [Related]
15. [Experience in using Prolia in patients with postmenopausal osteoporosis in clinical practice].
Skripnikova IA; Kosmatova OV; Abirova ES; Novikov VE; Murashko LM
Ter Arkh; 2017; 89(12. Vyp. 2):190-196. PubMed ID: 29488480
[TBL] [Abstract][Full Text] [Related]
16. Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.
Cirnigliaro CM; Myslinski MJ; La Fountaine MF; Kirshblum SC; Forrest GF; Bauman WA
Osteoporos Int; 2017 Mar; 28(3):747-765. PubMed ID: 27921146
[TBL] [Abstract][Full Text] [Related]
17. Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study.
McClung MR; Brown JP; Diez-Perez A; Resch H; Caminis J; Meisner P; Bolognese MA; Goemaere S; Bone HG; Zanchetta JR; Maddox J; Bray S; Grauer A
J Bone Miner Res; 2018 Aug; 33(8):1397-1406. PubMed ID: 29694685
[TBL] [Abstract][Full Text] [Related]
18. Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.
Egerdie RB; Saad F; Smith MR; Tammela TL; Heracek J; Sieber P; Ke C; Leder B; Dansey R; Goessl C
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):308-12. PubMed ID: 22641239
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of bisphosphonate analogues and functional electrical stimulation on attenuating post-injury osteoporosis in spinal cord injury patients- a systematic review and meta-analysis.
Chang KV; Hung CY; Chen WS; Lai MS; Chien KL; Han DS
PLoS One; 2013; 8(11):e81124. PubMed ID: 24278386
[TBL] [Abstract][Full Text] [Related]
20. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
